Paramount Gold Nevada Corp.
Paramount Gold Nevada Corp., trading as PZG, is an enterprise focused on discovering, obtaining, and advancing precious metal reserves across the United States. Its primary efforts are directed towards the exploration of gold and silver deposits. A key asset for the company is its principal stake in the Sleeper gold…
1D
+0.0%
1W
-8.6%
1M
-17.2%
6M
-40.8%
YTD
-15.9%
1Y
-9.4%
2Y
+152.4%
5Y
+26.2%
10Y
-44.2%
Next earnings date
13/11/2026 (in 27 days)
Volatility around earnings
~30% stronger price swings than usual
PRICE TARGET LOW
US$4.00
CONSENSUS
US$4.00
MEDIAN
US$4.00
PRICE TARGET HIGH
US$4.00
0
STRONG BUY
3
BUY
0
HOLD
0
SELL
0
STRONG SELL
3
TOTAL · Buy
As of: 31/08/2021
P/E
-5.37
P/B
2.69
EV/EBITDA
-6.4
RETURN ON EQUITY
-5.6%
NET MARGIN
0.0%
DEBT/EQUITY
0.35
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
FREE FLOAT
78.0%
FLOAT SHARES
67,271,275
AVG. DAILY VOLUME (30D)
272,000
Paramount Gold Nevada Corp. is a company in the Basic Materials sector, Gold industry, headquartered in United States.
The CEO is Rachel Louise Goldman, the company employs around 4 people.
The IPO was on 10/04/2015; the stock trades on AMEX under the ticker PZG.
3 analysts rate the stock, the consensus is Buy (as of 31/08/2021).
The average price target is US$4.00, ranging from US$4.00 to US$4.00, with a median of US$4.00.
This is an external assessment, not a statement by Market Jury.
The next earnings date is 13/11/2026.
Around past earnings, price swings were roughly 30% stronger than usual.
No, Paramount Gold Nevada currently does not pay a dividend.
Comparable stocks include Newmont, Coeur Mining, Hycroft Mining Holding, Metals Exploration, Southern Copper, Freeport-McMoRan, Ecolab and Sherwin-Williams Company.
Clicking "Analyze stock" lets five strategies assess Paramount Gold Nevada against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.